One manufacturer responsible for 26 contaminated eye drop products, FDA warnsnews2023-10-30T19:45:17+00:00October 30th, 2023|Endpoints News|
Pfizer cost cuts: Drugmaker closes sites in New Jersey, North Carolinanews2023-10-30T19:21:28+00:00October 30th, 2023|Endpoints News|
WuXi AppTec slashes 2023 growth revenue forecast in half due to drop in demand for early-stage servicesnews2023-10-30T19:11:13+00:00October 30th, 2023|Endpoints News|
Fertility benefits company Progyny shares how it handles startup valuations when looking for dealsnews2023-10-30T18:47:37+00:00October 30th, 2023|Endpoints News|
Boehringer Ingelheim pledges ‘Life forward’ with new corporate brandingnews2023-10-30T18:41:53+00:00October 30th, 2023|Endpoints News|
Senate Democrats urge Biden administration to require insurers to cover OTC birth controlnews2023-10-30T17:50:10+00:00October 30th, 2023|Endpoints News|
Novartis strikes a deal to buy bluebird’s potential priority review vouchernews2023-10-30T17:35:49+00:00October 30th, 2023|Endpoints News|
New pharmacy benefit managers coalition flips the script with an ad campaign advocating for legislationnews2023-10-30T17:24:09+00:00October 30th, 2023|Endpoints News|
Merck to boost Gardasil production; Increased demand for Sanofi’s RSV drug; Takeda addresses facility ‘impairment’ news2023-10-30T16:16:40+00:00October 30th, 2023|Endpoints News|
Deciphera Pharmaceuticals’ vimseltinib passes PhIII for TGCTnews2023-10-30T15:26:25+00:00October 30th, 2023|Endpoints News|
